BioCentury
ARTICLE | Finance

Hedging in Asia

How Ally Bridge may deploy new Asia-focused healthcare hedge fund

September 21, 2015 7:00 AM UTC

Ally Bridge Group expects its newest investment vehicle - an Asia-focused healthcare hedge fund - will have a surplus of buying opportunities given the plunge of the stock market in China. In other territories, such as Taiwan, the firm may take a more measured approach as it thinks a floor hasn't yet been found.

Frank Yu, formerly a managing director at Goldman Sachs and head of China investments at Och-Ziff Capital, founded Ally Bridge in 2013 to invest in healthcare companies globally and to help form partnerships between companies in China and those outside the country. The firm started with a private equity vehicle that is in the midst of raising money towards a $380 million target and invests in established healthcare companies in China and private biotechs in the U.S., Europe and Israel...